Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.108
-0.003 (-0.23%)
Sep 13, 2024, 9:44 AM EDT - Market open
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $25.20 million as of September 13, 2024. Its market cap has increased by 121.08% in one year.
Market Cap
25.20M
Enterprise Value
35.11M
1-Year Change
121.08%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $168.90M to $25.20M, a decrease of -85.08%. That is a compound annual growth rate of -26.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2024 | 24.00M | -6.61% |
| Dec 29, 2023 | 25.70M | 149.51% |
| Dec 30, 2022 | 10.30M | -85.61% |
| Dec 31, 2021 | 71.60M | 68.08% |
| Dec 31, 2020 | 42.60M | -36.32% |
| Dec 31, 2019 | 66.90M | -5.64% |
| Dec 31, 2018 | 70.90M | -58.02% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioXcel Therapeutics | 22.61M |
| Pieris Pharmaceuticals | 22.44M |
| Renalytix | 22.23M |
| The Oncology Institute | 22.22M |
| Brainstorm Cell Therapeutics | 22.16M |
| NeuroSense Therapeutics | 21.61M |
| NeurAxis | 21.41M |
| Lipocine | 21.34M |